Comienzos
keyboard_arrow_right
keyboard_arrow_right
Affymax initiates Phase 3 clinical screening of Hematide in Japan.
Nutrition

Affymax initiates Phase 3 clinical screening of Hematide in Japan.

The U.S. Phase 3 clinical program enrolled approximately 2,600 chronic renal failing patients at 400 scientific trial sites approximately. Source Affymax, Inc.. Affymax initiates Phase 3 clinical screening of Hematide in Japan, receives $5M milestone payment Affymax, Inc. The milestone was accomplished with the initiation of Stage 3 clinical screening of Hematide to treat anemia in chronic renal failure individuals in Japan. Related StoriesAmgen gets positive CHMP opinions for Kyprolis and BLINCYTO Amgen announces submission of supplemental New Medication Software to FDA for Kyprolis New medical data demonstrating treatment plans in Lilly's diabetes portfolio to be presented in ADA Scientific Sessions Affymax and Takeda are collaborating on the advancement of Hematide and will co-commercialize the product in the United States.MMR assists healthcare specialists searching for effective electronic document administration solutions. The MyMedicalRecords consumer-controlled multilingual Personal Health Record, available at streamlines the process of sharing health info between doctors and their individuals. To date, a lot more than 500,000 users get access to MMR’s PHR item network. Kodak’s document capture software and scanners couple performance and ease of use to improve the accuracy and effectiveness of processing high quality pictures from paper-based files. These precision-driven document catch capabilities allows healthcare professionals to upload and access patient details in real-time using MMR’s Web-based, Software-as-a-Assistance applications, including mymedicalrecordsmd.com, mmrpatientview.mymedicalrecords and com.com.